申请人:Pfizer Inc.
公开号:US06258953B1
公开(公告)日:2001-07-10
Compounds of the formula
wherein R1, R2, R3, R4, R5 and X are defined as in the specification. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and antagonists.
该公式中R1、R2、R3、R4、R5和X的化合物如规范中定义。这些化合物是有用的精神治疗药物,是强效的5-羟色胺(5-HT1)激动剂和拮抗剂。